住友ファーマ創出の新規TLR7ワクチンアジュバント（DSP-0546）を用いた新規ユニバーサルインフルエンザワクチン候補製剤の欧州フェーズ1試験における最終解析結果の速報について

Sumitomo Pharma Co. Ltd. published this content on September 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 30, 2026 at 06:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]